The increase of the drug therapy rationality in an elderly patient of the therapeutic profile
DOI:
https://doi.org/10.24959/cphj.18.1453Keywords:
risks associated with the use of drugs, polypragmasy, side effects of medicines, elderly patientsAbstract
Taking into account the tendency to aging population around the world, as well as the frequency of occurrence, polymorbidity and peculiarities of the course of the concomitant pathology in elderly the increase of the rationality of pharmacotherapy in this group of patients has a significant medical and social value.
Aim. To increase the rational use of drugs in the elderly and old age.
Materials and methods. 105 Inpatient medical histories of patients aged over 65 years old were analyzed for the purpose of conformity of drug prescribing with the international recommendations of the American Geriatric Association of 2015. These recommendations included the correlation of a particular drug to the category of drugs that are not recommended for use in the elderly or the category of drugs which use should be avoided in certain diseases and syndromes, or potentially dangerous.
Results. In 73 % of cases there were prescriptions of drugs included in the list of those that were not recommended in elderly patients with different strength of evidence and contraindications. In addition, in 34.4 % of observations, the inappropriateness of the prescription of individual drugs was identified, and in 57.1 % there was incorrect dosing according to the standardized Medication Appropriateness Index. A high level of polypragmasy was revealed.
Conclusions. Conclusions are made concerning the ways of improving the rationality of drug therapy of elderly patients.
References
Mishchenko, T. S. (2017). Ukrainskyi visnyk psykhonevrolohii, 25 (1), 22–24.
Garcia–Alvarez, A., Egan, B., de Klein, S., Dima, L., Maggi, F. M., Isoniemi, M., Serra–Majem, L. (2014). Usage of Plant Food Supplements across Six European Countries: Findings from the PlantLIBRA Consumer Survey. PLoS ONE, 9 (3), e92265. doi: 10.1371/journal.pone.0092265
Simanenkov, V. I. (2008). Consilium Medicum, 2 (1), 12–21.
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. (2015). Journal of the American Geriatrics Society, 63 (11), 2227–2246. doi: 10.1111/jgs.13702
Somers, A., Mallet, L., van der Cammen, T., Robays, H., Petrovic, M. (2012). Applicability of an Adapted Medication Appropriateness Index for Detection of Drug–Related Problems in Geriatric Inpatients. The American Journal of Geriatric Pharmacotherapy, 10 (2), 101–109. doi: 10.1016/j.amjopharm.2012.01.003
Lehman, A. F., Lieberman, J. A., Dixon, L. B. et al. (2004). Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry, 161 (2), S–56S.
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H. (2013). 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 128 (16), e240–e327. doi: 10.1161/cir.0b013e31829e8776
Zborovskaia I. L. (2005). Gastropatii, indutsirovannye nesteroidnymi protivovospalitelnymi preparatami: klinicheskoe znachenie, lechenie, profilaktika. Volgograd, 16.
Schellack, N. (2012). An overview of gastropathy induced by nonsteroidal anti–inflammatory drugs. S Afr Pharm J., 79 (4), 12–18
Sychev, D. A., Danilina, K. S., Otdelenov, V. A. (2013). Klinicheskaia farmakologiia i terapiia, 22 (2), 1–6.
Sadyrova, Zh. A., Zamzaeva, B. D., Abuova, D. K. et al. (2014). Vestnik KazNMU, 1 (1), 47–50.
Fischer, G. W., Trigo, P. (2011). Managing atrial fibrillation in the elderly: critical appraisal of dronedarone. Clinical Interventions in Aging, 1. doi: 10.2147/cia.s16677
Opi, L. Kh., Gersh, B. D., Khirmanov, V. N. (2010). Lekarstva v praktike kardiologa. Moscow: Rid Elsiver, 784.
Moroz, V. A., Grintcov, Ye. F. (2016). Eksperymentalna i klinichna medytsyna, 70 (1), 52–58
Moroz, V.A. (2013). Pharmaceutical care in the treatment of patients with lower urinary tract infections. Annals of Mechnikov’s Institute, 2, 10–15.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
